Aller au contenu principal
2023 review

Impact of Vasodilator Administration on Survival in Patients with Sepsis: A Systematic Review and Meta-Analysis

4Citations signalées, ce qui n’est pas une note de qualité
4Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : us, fr. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Rationale Sepsis and septic shock are associated with microcirculatory dysfunction, which is believed to contribute to sepsis-induced organ failure. Vasodilators have been proposed to improve tissue perfusion in sepsis, but the overall survival impact of this strategy is unclear. Objectives To evaluate the impact of systemic vasodilator administration in patients with sepsis and septic shock on mortality. Methods We conducted a meta-analysis using a random effects model. Published and unpublished randomized trials in adult patients with sepsis and septic shock were included when comparing the use of systemic vasodilators against no vasodilators. The primary outcome was 28–30-day mortality, and secondary outcomes were organ function and resource use measures. Results We included eight randomized trials (1,076 patients). In patients randomized to vasodilator arms compared with those randomized to treatment without vasodilators, the 28–30-day mortality risk ratio was 0.74 (95% confidence interval, 0.54–1.01). In a chronological cumulative meta-analysis, the association between vasodilators and survival improved over time. In a prespecified subgroup analysis in 104 patients in two randomized trials, prostacyclin analogues were associated with a decreased rate of 28–30-day mortality among patients with sepsis and septic shock (risk ratio, 0.46; 95% confidence interval, 0.25–0.85). Conclusions In patients with sepsis and septic shock, administration of vasodilators is not associated with decreased 28–30-day mortality, but the confidence interval suggests potential benefit, and the meta-analysis might lack power. Prostacyclin appears the most promising. The results of this meta-analysis should encourage randomized trials evaluating the impact of vasodilators on mortality in sepsis.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Impact of Vasodilator Administration on Survival in Patients with Sepsis: A Systematic Review and Meta-Analysis
Date Crossref
01/09/2023
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyIntensive Care Unit Cognitive Disorders

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.